The Hungarian government has no plans to send military equipment to Ukraine, according to the deputy foreign minister, sticking with the policy adopted by the previous nationalist leader Viktor Orban.
The average one-year price target for AMREP (NYSE:AXR) has been revised to $22.44 / share. This is a decrease of 15.38% from the prior estimate of $26.52 dated September 11, 2026. These figures represent aggregate analyst targets compiled by Fintel and do not constitute a recomme
The average one-year price target for AMREP (NYSE:AXR) has been revised to $22.44 / share. This is a decrease of 15.38% from the prior estimate of $26.52 dated September 11, 2026. These figures represent aggregate analyst targets compiled by Fintel and do not constitute a recomme
Ties between the U.S. and India have been under strain for over a year, and New Delhi faces fresh risk of up to 100% tariffs for continuing to buy Russian oil.
Ties between the U.S. and India have been under strain for over a year, and New Delhi faces fresh risk of up to 100% tariffs for continuing to buy Russian oil.
Ties between the U.S. and India have been under strain for over a year, and New Delhi faces fresh risk of up to 100% tariffs for continuing to buy Russian oil.
Ties between the U.S. and India have been under strain for over a year, and New Delhi faces fresh risk of up to 100% tariffs for continuing to buy Russian oil.
Soybeans bounced off the intraday lows on Thursday, with contracts closing 7 to 9 cents lower in the nearbys and down 1 3/4 to 6 ½ cents in deferreds. The cmdtyView national average Cash Bean price was down 10 1/2 cents at $12.29. Soymeal futures were down $1.50 to $5.00...
Soybeans bounced off the intraday lows on Thursday, with contracts closing 7 to 9 cents lower in the nearbys and down 1 3/4 to 6 ½ cents in deferreds. The cmdtyView national average Cash Bean price was down 10 1/2 cents at $12.29. Soymeal futures were down $1.50 to $5.00...
Hong Kong’s stock benchmark led losses in Asia as trading resumed after a holiday, pressured by the recent surge in US yields and disappointment over China’s latest stimulus measures.
(RTTNews) - Thursday, Edwards Lifesciences (EW) announced that the U.S. FDA approved the AUTUS Size-Adjustable Valve, the first surgical pulmonary valve designed specifically for pediatric patients with congenital heart disease.
(RTTNews) - Thursday, Edwards Lifesciences (EW) announced that the U.S. FDA approved the AUTUS Size-Adjustable Valve, the first surgical pulmonary valve designed specifically for pediatric patients with congenital heart disease.